279
Views
8
CrossRef citations to date
0
Altmetric
Research Article

A chitosan lactate/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: design and in vitro evaluation

, , , , , & show all
Pages 1911-1920 | Received 04 Feb 2012, Accepted 14 May 2012, Published online: 08 Jun 2012

References

  • Sobel JD. (2007). Vulvovaginal candidosis. Lancet, 369:1961–1971.
  • das Neves J, Pinto E, Teixeira B, Dias G, Rocha P, Cunha T et al. (2008). Local treatment of vulvovaginal candidosis: general and practical considerations. Drugs, 68:1787–1802.
  • Valenta C. (2005). The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev, 57:1692–1712.
  • Brown J, Hooper G, Kenyon CJ, Haines S, Burt J, Humphries JM et al. (1997). Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy. Pharm Res, 14:1073–1078.
  • Kast CE, Valenta C, Leopold M, Bernkop-Schnürch A. (2002). Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J Control Release, 81:347–354.
  • Yoo JW, Dharmala K, Lee CH. (2006). The physicodynamic properties of mucoadhesive polymeric films developed as female controlled drug delivery system. Int J Pharm, 309:139–145.
  • Bouckaert S, Temmerman M, Voorspoels J, Van Kets H, Remon JP, Dhont M. (1995). Preliminary efficacy study of a bioadhesive vaginal metronidazole tablet in the treatment of bacterial vaginosis. J Pharm Pharmacol, 47:970–971.
  • Chang JY, Oh YK, Kong HS, Kim EJ, Jang DD, Nam KT et al. (2002). Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release, 82:39–50.
  • Ning MY, Guo YZ, Pan HZ, Chen XL, Gu ZW. Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Dev Ind Pharm. 2005;31:375–383.
  • Pavelic Z, Skalko-Basnet N, Filipovic-Grcic J, Martinac A, Jalsenjak I. (2005). Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J Control Release, 106:34–43.
  • Thirawong N, Thongborisute J, Takeuchi H, Sriamornsak P. (2008). Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes. J Control Release, 125:236–245.
  • O’Hagan DT, Rafferty D, Wharton S, Illum L. (1993). Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system. Vaccine, 11:660–664.
  • Hunter SK, Andracki ME, Krieg AM. (2001). Biodegradable microspheres containing group B Streptococcus vaccine: immune response in mice. Am J Obstet Gynecol, 185:1174–1179.
  • Karn PR, Vanic Z, Pepic I, Skalko-Basnet N. (2011). Mucoadhesive liposomal delivery systems: the choice of coating material. Drug Dev Ind Pharm, 37:482–488.
  • Gavini E, Sanna V, Juliano C, Bonferoni MC, Giunchedi P. (2002). Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine. AAPS PharmSciTech, 3:E20.
  • Albertini B, Passerini N, Di Sabatino M, Vitali B, Brigidi P, Rodriguez L. (2009). Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate. Eur J Pharm Sci, 36:591–601.
  • Kumar M. A review of chitin and chitosan applications. React Funct Polym. 2000;46:1–27.
  • Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. (2004). Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release, 100:5–28.
  • Perioli L, Ambrogi V, Venezia L, Pagano C, Ricci M, Rossi C. (2008). Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels. Colloids Surf B Biointerfaces, 66:141–145.
  • Cafaggi S, Leardi R, Parodi B, Caviglioli G, Russo E, Bignardi G. (2005). Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery. J Control Release, 102:159–169.
  • Desai SD, Blanchard J. (1998). In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine. J Pharm Sci, 87:226–230.
  • Czeizel AE, Kazy Z, Vargha P. (2003). A population-based case-control teratological study of vaginal econazole treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol, 111:135–140.
  • Adibkia K, Javadzadeh Y, Dastmalchi S, Mohammadi G, Niri FK, Alaei-Beirami M. (2011). Naproxen-eudragit RS100 nanoparticles: preparation and physicochemical characterization. Colloids Surf B Biointerfaces, 83:155–159.
  • Fujimori J, Yoshihashi Y, Yonemochi E, Terada K. (2005). Application of Eudragit RS to thermo-sensitive drug delivery systems: II. Effect of temperature on drug permeability through membrane consisting of Eudragit RS/PEG 400 blend polymers. J Control Release, 102:49–57.
  • Haznedar S, Dortunç B. (2004). Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm, 269:131–140.
  • Kramar A, Turk S, Vrecer F. (2003). Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films. Int J Pharm, 256:43–52.
  • González-Rodríguez ML, Maestrelli F, Mura P, Rabasco AM. (2003). In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery. Eur J Pharm Sci, 20:125–131.
  • Narisawa S, Nagata M, Hirakawa Y, Kobayashi M, Yoshino H. (1996). An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid. J Pharm Sci, 85:184–188.
  • Maghsoodi M, Sadeghpoor F. (2010). Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique. Drug Dev Ind Pharm, 36:917–925.
  • Korsmeyer R, Gurny R, Doelker E, Buri P, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.
  • Parodi B, Russo E, Gatti P, Cafaggi S, Bignardi G. (1999). Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane. Drug Dev Ind Pharm, 25:289–295.
  • Tao YY, Lu YF, Sun YJ, Gu B, Lu WY, Pan J. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability. Int J Pharm. 2009;378:30–36.
  • Alhnan MA, Basit AW. (2011). In-process crystallization of acidic drugs in acrylic microparticle systems: influence of physical factors and drug-polymer interactions. J Pharm Sci, 100:3284–3293.
  • Hombreiro-Pérez M, Siepmann J, Zinutti C, Lamprecht A, Ubrich N, Hoffman M et al. (2003). Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling. J Control Release, 88:413–428.
  • Huang J, Wigent RJ, Schwartz JB. (2008). Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend. J Pharm Sci, 97:251–262.
  • Dvorácková K, Rabisková M, Masteiková R, Muselík J, Krejcová K. (2009). Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets. Drug Dev Ind Pharm, 35:930–940.
  • Efentakis M, Buckton G. (2002). The effect of erosion and swelling on the dissolution of theophylline from low and high viscosity sodium alginate matrices. Pharm Dev Technol, 7:69–77.
  • Rokhade AP, Shelke NB, Patil SA, Aminabhavi TM. (2007). Novel hydrogel microspheres of chitosan and pluronic F-127 for controlled release of 5-fluorouracil. J Microencapsul, 24:274–288.
  • Angadi SC, Manjeshwar LS, Aminabhavi TM. Stearic acid-coated chitosan-based interpenetrating polymer network microspheres: Controlled release characteristics. Indust Engg Chemistry Res. 2011;50:4504–4514.
  • Agnihotri SA, Aminabhavi TM. (2007). Chitosan nanoparticles for prolonged delivery of timolol maleate. Drug Dev Ind Pharm, 33:1254–1262.
  • Liu YH, Zhu X, Zhou D, Jin Y, Zhao CY, Zhang ZR et al. (2011). pH-sensitive and mucoadhesive microspheres for duodenum-specific drug delivery system. Drug Dev Ind Pharm, 37:868–874.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.